Latest / Jersey City News Today | 2 Min News | The Daily News Now!
Melanoma Vaccine Breakthrough with Keytruda | Jersey News
Moderna and Merck just dropped a game-changing update: their personalized mRNA melanoma vaccine, paired with Keytruda, slashes recurrence risk in high-risk patients—though it’s not yet FDA-approved. With over 1,000 trial participants showing better outcomes than Keytruda alone, this combo could redefine cancer treatment. Experts predict potential approval by 2027 if FDA review goes smoothly—bringing us closer to a new era of precision oncology. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.